pH Partners Serves as Exclusive Financial Advisor to VeruStat, Inc. NEW YORK, NY, USA, December 18, 2023 –- pH Partners is pleased to announce that today, our client VeruStat, Inc. (“VeruStat”) has completed a sale of substantially all its assets to CoachCare,...
pH Partners Serves as Exclusive Financial Advisor to Lynch Biologics, LLC Franklin, TN, October 27, 2022 — pH Partners, LLC, a healthcare investment bank, is pleased to announce that its client, Lynch Biologics, LLC, founded by Dr. Sam Lynch, DMD, DMSC, has been...
Plano, TX, July 28, 2022 – pH Partners, LLC (“PHP”), a boutique healthcare investment bank, is pleased to announce that its client Medi-Lynx Cardiac Monitoring, LLC (“Medi-Lynx”), a U.S subsidiary of Medicalgorithmics S.A., has completed its sale to React Health...
EDMONTON, AB, November 15, 2021 – pH Partners, LLC (“PHP”) is excited to announce the partnership between Entos Pharmaceuticals and BioMarin Pharmaceutical Inc. to develop new treatments for a host of genetic diseases. Erik Halvorsen, the lead Partner from...
